<DOC>
	<DOC>NCT00195429</DOC>
	<brief_summary>This study evaluates two different immunosuppression drug regimens in patients with a recent kidney transplant. Patients initially received a regimen of Sirolimus, Tacrolimus and Prednisone and then randomized to discontinue either Tacrolimus or Prednisone.</brief_summary>
	<brief_title>A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Graft vs Host Disease</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Endstage renal disease, with patients scheduled to receive a kidney transplant. Women who are of childbearing potential who are not pregnant and agree to use a medically acceptable method of contraception throughout the treatment period and for 3 months following discontinuation of study drugs. Any woman becoming pregnant during the treatment period must discontinue the use of study drugs; Signed informed consent. Evidence of active systemic or localized major infection at the time of initial study drug administration; Multiple organ transplants; Any pathology or medical condition that can interfere with this protocol study proposal. Other exclusion applies.</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Kidney</keyword>
	<keyword>Transplant</keyword>
</DOC>